Rebimox-CV 625 Tablet
By Rebimox-CV
Rx
10 Tablet in a Strip

Composition
Amoxycillin(500mg) + Clavulanic Acid(125mg)

Manufacturer - Rebanta Health Care (P) Limited
9, Hansa Apartment II, Kalyan West, Thane - 421301

Expires on or after
September, 2025

liver
When taking Rebimox-CV 625 Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment while using this medication. It is advised to consult your doctor before starting the treatment with Rebimox-CV 625 Tablet. Regular monitoring of liver function tests is also recommended to ensure the medication is not causing any harm to your liver.

kidney
Rebimox-CV 625 Tablet requires caution for patients with kidney disease. Dosage adjustment may be necessary. Avoid usage in severe kidney disease. Consult your doctor for personalized advice.

alcohol
When taking Rebimox-CV 625 Tablet, drinking alcohol does not lead to harmful side effects.

driving
Rebimox-CV 625 Tablet may cause side effects like allergic reactions, dizziness, or fits which may affect driving ability. Refrain from driving if experiencing symptoms impairing focus or reaction time.

pregnancy
Rebimox-CV 625 Tablet is generally safe during pregnancy. Limited human studies show low risk, but it's always best to consult your doctor before using it while pregnant.

breastfeeding
Rebimox-CV 625 Tablet is considered safe to use while breastfeeding. Studies indicate that the medication does not transfer to breastmilk in harmful concentrations. It is safe for both the mother and the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹196.6
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024